OA12.05 Surgical Outcomes with Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC (AEGEAN) by Mitsudomi, T., Heymach, J.V., Reck, M., Taube, J.M., Gao, S., Horio, Y., You, J., Li, G., Van Luong, D., Saeteng, S., Tanaka, F., Kulesza, G., Watzka, S.B., Urban, L., Szalai, Z., Akamatsu, H., Kang, J.-H., Orlandi, F.J., Mukhametshina, G.Z., Pircher, A., Teixeira, C.H.A., Aperghis, M., Doherty, G.J., Doake, R., Fouad, T.M., Harpole, D.

Get full text

OA12.06 First-Line Pembrolizumab or Placebo Combined with Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results by Rudin, C.M., Kim, H.R., Navarro, A., Gottfried, M., Peters, S., Csőszi, T., Cheema, P.K., Rodriguez-Abreu, D., Wollner, M., Czyżewicz, G., Yang, J.C.-H., Mazieres, J., Orlandi, F.J., Luft, A., Gümüş, M., Kato, T., Kalemkerian, G.P., Fu, W., Zhao, B., El-Osta, H., Awad, M.M.

Get full text

Guideline for patients undergoing chemoembolization by Salazar, J., Villena, M.P., Vilugron, E., Orlandi, F.J.

Get full text

On the mechanism of charge transport in pentacene by v. Laarhoven, H. A., Flipse, C. F. J., Koeberg, M., Bonn, M., Hendry, E., Orlandi, G., Jurchescu, O. D., Palstra, T. T. M., Troisi, A.

Get full text

Rainfall assimilation in RAMS by means of the Kuo parameterisation inversion: method and preliminary results by Orlandi, A, Ortolani, A, Meneguzzo, F, Levizzani, V, Torricella, F, Turk, F.J

Get full text